Chinese e-commerce ready to conquer the health market

With a value of 122.6 billion dollars in 2017, which in 2022 will reach a figure of 145 and 175 billion dollars, the Chinese pharmaceutical market was the second largest in the world, after the US. A huge development that has not gone unnoticed by Alibaba, the Chinese colossus of e-commerce, who last June after […]

PQE Awarded among italian Excellences of 2018

PQE among the Excellences of Italy in 2018

PQE Group has been named among the excellent companies of 2018 in Italy according to the research conducted by the Osservatorio PMI carried out by Global Strategy, a strategic and financial consulting firm that presented the results of the tenth edition yesterday at Palazzo Mezzanotte, Stock Exchange Headquarters in Milan. In this tenth edition, 724 […]

GDPR General Data Protection Regulation PQE Pharma DOTS

EU: GDPR is now a reality

Published today in the Official Bulletin of the State, the legislative decree number 101/2018 aligns Italy to the GDPR rules that have been released on May 25th. The decree will be active from September 19, 2018 and aims to bring a step forward for the transparency in the relations between patients and health service; as […]

New GILS rules powered by PQE

PQE and SID&GP, together for Data Integrity guidance

PQE Group is proud to announce that the draft of the new Russian Guide for Industrial Data Integrity has been published on the website of GILS – Russian State Institute of Drugs and Good Practices. After the collaboration with COFEPRIS, the Mexican Regulatory Authority, for the creation of the data integrity chapter of the NOM […]

3rd PDA Europe Annual Meeting

Audit Trails Review: PQE leader of Pharma Coalition

On Wednesday 27th of June has been presented at the 3rd PDA Europe Annual Meeting in Berlin a white paper about the issue of the Audit Trails Review. The ongoing theme of the European Annual Meeting is Global Healthcare of the Present & the Future, as it intends to continue spanning a bridge between current […]